Glucotrack, Inc. GCTK
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2013-04-09
Glucotrack, Inc. statistics & valuation
Market cap$2.1M
P / B0.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -247.4% | -380.9% | -144.7% | -181.9% | -64.9% |
| Return on equity | -685.6% | 173.8% | -222.0% | -360.6% | -78.9% |
| Current ratio | 1.61 | 4.52 | 3.22 | 2.35 | 6.91 |
Source: SEC EDGAR filings · CIK 0001506983 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.